AUG 13, 2026 · JOURNAL ARTICLE
MMP14-engineered biomimetic nanodrug for intratumoral antibacterial therapy suppresses colorectal cancer growth and liver metastasis
Journal of Nanobiotechnology
Early-stage preclinical study demonstrating proof-of-concept for a novel nanodrug in mouse models of colorectal cancer; no human efficacy data, clinical outcomes, or comparative efficacy trial provided.
Reported
Primary outcome measureSubcutaneous tumor growth and liver metasta…
Immune response markerEnhanced CD8+ T-cell infiltration
Bacterial burdenDecreased intratumoral Fn signals